News | October 22, 2021
Gland Pharma PAT declines to Rs 302 crore QoQ in Q2FY22
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
It has planned an investment of over Rs 80 crore in the next five years
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The company plans to expand its portfolio in regulated markets aggressively
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Subscribe To Our Newsletter & Stay Updated
